Featured Research

from universities, journals, and other organizations

Drug-eluting balloons are a promising tool in treatment of narrowed metal stents and in patients at high risk for bleeding complications

Date:
November 29, 2011
Source:
American Heart Association
Summary:
A drug-coated balloon inserted in a narrowed bare metal stent is a promising therapy for restoring blood flow, according to new research.

A drug-coated balloon inserted in a narrowed bare metal stent is a promising therapy for restoring blood flow, according to research presented at the American Heart Association's Scientific Sessions 2011.

Related Articles


In this study, the drug-eluting balloon reduced the development of scar tissue within existing, narrowed bare metal stents as effectively as drug-eluting stents.

Bare metal stents inserted into a blood vessel to prop it open can become narrowed over time through the development of the scar tissue (neomyointima), thus restricting blood flow (in-stent stenosis).

"The current approach of placing a metal drug-eluting stent inside an old bare metal stent essentially creates a metal sandwich," said Mariusz Zadura, M.D., lead researcher and senior cardiologist at the Heart and Diabetes Center of Mecklenburg-Vorpommern in Karlsburg, Germany.

"With drug-eluting balloons, we can reduce the body's reaction to a full-metal jacket placed in an artery because the biodegradable balloon coating material (matrix) decomposes in 24 hours and appears to create less of an immune reaction."

The researchers retrospectively compared the responses of 84 patients who underwent procedures to reopen narrowed bare metal stents and restore blood flow (revascularization) with drug-eluting balloons coated with the drug paclitaxel.

Physicians treated 91 lesions (narrowed areas) in men and women averaging 67.5 years old.

After six to nine months, the balloon still kept 85 of the lesions open. There were new narrowed areas in six stents, but only three patients required an additional procedure.

Drug-eluting metal stents can cause additional blood clots as their medication is released over a six to eight week period. Because drug-coated balloons operate for a very short time, the body seems to accept them as being less "alien" and tends to have a milder reaction to their placement, researchers said.

These findings complement other studies and "give a new argument from the real-life conditions in how to better perform repeated procedures to clear in-stent stenosis," Zadura said. "We consider the drug-eluting balloon technique the best option for in-stent restenosis in clinical practice."

Bleeding risk lower with drug-coated balloons

In another study, the same researchers found that drug-eluting balloons are a feasible option for patients with a high risk of bleeding complications because of their health status, since the balloon treatment requires a shorter anticoagulation period.

Patients who are treated with drug-eluting metal stents require daily aspirin and clopidogrel for at least one year, which can cause unwanted bleeding. An advantage for patients who receive a drug-coated balloon is that they only need to take such dual antiplatelet therapy for one month.

High-risk patients include those with mechanical prosthetic heart valves, atrial fibrillation and pulmonary embolism treated continuously within oral anticoagulants (warfarin or phenprocoumon).

The researchers followed 63 patients with de novo lesions (narrowed areas) being treated with drug-eluting balloons and after six to nine months they found no significant re-narrowing in 69 of 73 lesions. While four lesions showed a repeated narrowing, only two patients required a subsequent targeted revascularization.

"This is a major benefit, especially in elderly or non-compliant patients," Zadura said. "Due to the reduced need for dual platelet inhibition, drug-eluting balloons seem to be an interesting alternative."

Resembling tiny springs, bare metal stents are tubular scaffolds inserted into an obstructed artery to prop it open to help blood flow freely. Many patients with bare metal stents experience accelerated tissue growth in the artery lining after insertion, with re-blockage, often within the first six months.

Co-authors of both studies are Frank Szigat, M.D.; Birger Wolff, M.D.; Peter Szigat, M.D.; Ronald Bittner, M.D.; Barnaba Hejazin, M.D.; and Wolfgang Motz, M.D.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Drug-eluting balloons are a promising tool in treatment of narrowed metal stents and in patients at high risk for bleeding complications." ScienceDaily. ScienceDaily, 29 November 2011. <www.sciencedaily.com/releases/2011/11/111116104338.htm>.
American Heart Association. (2011, November 29). Drug-eluting balloons are a promising tool in treatment of narrowed metal stents and in patients at high risk for bleeding complications. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2011/11/111116104338.htm
American Heart Association. "Drug-eluting balloons are a promising tool in treatment of narrowed metal stents and in patients at high risk for bleeding complications." ScienceDaily. www.sciencedaily.com/releases/2011/11/111116104338.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins